🇮🇳IN
Sign In
RE

REMUS

NSE

REMUS PHARMACEUTICALS L

₹880.60

-20.60(-2.29%)

Ownership Score

Index Membership

and the weight we carry

Mutual Fund Ownership

% of each scheme's portfolio

Insider & Deals

who traded, and how close they are to the company

Ownership & Influence

who holds it, and what else they hold

Shared directors

companies with a board member in common

REMUS shareholding summary

As of Sep 2026, promoters held 70.95% of REMUS PHARMACEUTICALS L. Institutions together held 5.53%, of which foreign institutional investors held 5.10% (down 0.18 points from Mar 2026) and domestic institutions held 0.43% (down 0.40 points from Mar 2026). The public held the remaining 23.52% (up 0.59 points from Mar 2026). The company had 2,092 shareholders.

Promoters70.95%
FII5.10%
DII0.43%
Public23.52%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer